Low density lipoprotein receptor expression on keratinocytes in normal and psoriatic epidermis.
Biochemical and morphologic studies on the interaction of low density lipoprotein (LDL) with cultured normal keratinocytes and squamous carcinoma cells have shown a negative correlation between LDL receptor activity and terminal differentiation of the epidermal cells [Ponec M et al, J Invest Dermatol 83:436-440, 1984 and Vermeer, BJ et al, J Invest Dermatol 86:195-200, 1986]. Whether such in vitro studies pertain to the epidermis in vivo is not known. To obtain information on the distribution of LDL receptors in the epidermis in situ, morphologic studies were performed using LDL-gold as an ultrastructural marker. When freshly isolated mouse and human epidermal cells were incubated with LDL-gold complexes, only keratinocytes with the morphologic characteristics of basal cells showed binding and uptake of LDL-gold. No LDL receptor activity was found on Langerhans cells, melanocytes or highly differentiated keratinocytes. Since cell separation techniques can destroy receptors, the staphylococcal epidermolytic toxin was utilized to produce intercellular and intra-epithelial splitting of the epidermis. In preparations of both normal mouse and human epidermis, LDL-gold binding was restricted to basal cells and a few suprabasal keratinocytes. In contrast, in psoriatic epidermis, and to a lesser extent, essential fatty acid-deficient mouse epidermis, cells in the stratum spinosum showed abundant LDL-gold binding. Thus LDL-gold may be a useful marker for epidermal differentiation.
Mommaas-Kienhuis
A M
AM
Department of Dermatology, University Medical Center, Leiden, The Netherlands.
Grayson
S
S
Wijsman
M C
MC
Vermeer
B J
BJ
Elias
P M
PM
D000818:Animals; D001427:Bacterial Toxins / Q000494:pharmacology; D002454:Cell Differentiation; D002469:Cell Separation / Q000379:methods; D002478:Cells, Cultured; D004817:Epidermis / Q000032:analysis* / Q000473:pathology; D005228:Fatty Acids, Essential / Q000172:deficiency; D006801:Humans; D006965:Hyperplasia; D008052:Lipid Metabolism, Inborn Errors / Q000473:pathology; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008297:Male; D051379:Mice; D008812:Mice, Hairless; D008817:Mice, Mutant Strains; D011565:Psoriasis / Q000378:metabolism* / Q000473:pathology; D011973:Receptors, LDL / Q000032:analysis*; D013212:Staphylococcus epidermidis; D014357:Trypsin / Q000494:pharmacology
D001427:Bacterial Toxins; D005228:Fatty Acids, Essential; D008077:Lipoproteins, LDL; D011973:Receptors, LDL; D014357:Trypsin